Found: 110
Select item for more details and to access through your institution.
Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors.
- Published in:
- Prostate, 2000, v. 44, n. 2, p. 156, doi. 10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8
- By:
- Publication type:
- Article
Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk disease.
- Published in:
- BJU International, 2012, v. 110, n. 6, p. 821, doi. 10.1111/j.1464-410X.2011.10868.x
- By:
- Publication type:
- Article
The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
- Published in:
- BJU International, 2012, v. 110, n. 1, p. 36, doi. 10.1111/j.1464-410X.2011.10681.x
- By:
- Publication type:
- Article
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours.
- Published in:
- BJU International, 2012, v. 109, n. 5, p. 660, doi. 10.1111/j.1464-410X.2011.10543.x
- By:
- Publication type:
- Article
Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence.
- Published in:
- BJU International, 2011, v. 108, n. 8b, p. E202, doi. 10.1111/j.1464-410X.2011.10119.x
- By:
- Publication type:
- Article
Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy.
- Published in:
- BJU International, 2009, v. 103, n. 7, p. 978, doi. 10.1111/j.1464-410X.2008.08132.x
- By:
- Publication type:
- Article
Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.
- Published in:
- BJU International, 2009, v. 103, n. 3, p. 384, doi. 10.1111/j.1464-410X.2008.08098.x
- By:
- Publication type:
- Article
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
- Published in:
- BJU International, 2008, v. 102, n. 5, p. 610, doi. 10.1111/j.1464-410X.2008.07669.x
- By:
- Publication type:
- Article
Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy.
- Published in:
- BJU International, 2008, v. 102, n. 3, p. 389, doi. 10.1111/j.1464-410X.2008.07618.x
- By:
- Publication type:
- Article
Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
- Published in:
- BJU International, 2008, v. 101, n. 11, p. 1347, doi. 10.1111/j.1464-410X.2008.07571.x
- By:
- Publication type:
- Article
Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
- Published in:
- BJU International, 2008, v. 101, n. 8, p. 982, doi. 10.1111/j.1464-410X.2007.07349.x
- By:
- Publication type:
- Article
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.
- Published in:
- BJU International, 2007, v. 100, n. 6, p. 1377, doi. 10.1111/j.1464-410X.2007.07165.x
- By:
- Publication type:
- Article
Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
- Published in:
- BJU International, 2006, v. 97, n. 6, p. 1300, doi. 10.1111/j.1464-410X.2006.06147.x
- By:
- Publication type:
- Article
The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 11, p. N.PAG, doi. 10.15252/emmm.201910659
- By:
- Publication type:
- Article
Co‐targeting driver pathways in prostate cancer: two birds with one stone.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 4, p. 1, doi. 10.15252/emmm.201808928
- By:
- Publication type:
- Article
Targeting the adaptive molecular landscape of castration-resistant prostate cancer.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 7, p. 878, doi. 10.15252/emmm.201303701
- By:
- Publication type:
- Article
Evaluation of the prognostic impact of pyknotic nuclei in prostate cancer cells: A retrospective cohort study.
- Published in:
- Canadian Journal of Pathology, 2018, v. 10, p. 41
- By:
- Publication type:
- Article
Development of Novel Inhibitors Targeting the D-Box of the DNA Binding Domain of Androgen Receptor.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 5, p. 2493, doi. 10.3390/ijms22052493
- By:
- Publication type:
- Article
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 2, p. 487, doi. 10.3390/ijms22020487
- By:
- Publication type:
- Article
Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2013, v. 14, n. 4, p. 7757, doi. 10.3390/ijms14047757
- By:
- Publication type:
- Article
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells.
- Published in:
- International Journal of Cancer, 1994, v. 57, n. 3, p. 406, doi. 10.1002/ijc.2910570319
- By:
- Publication type:
- Article
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21860-7
- By:
- Publication type:
- Article
Design and Characterization of Injectable Poly(Lactic-Co-Glycolic Acid) Pastes for Sustained and Local Drug Release.
- Published in:
- Pharmaceutical Research, 2020, v. 37, n. 3, p. 1, doi. 10.1007/s11095-019-2730-4
- By:
- Publication type:
- Article
Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer.
- Published in:
- Asian Journal of Andrology, 2013, v. 15, n. 3, p. 342, doi. 10.1038/aja.2013.38
- By:
- Publication type:
- Article
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 278, doi. 10.1007/s10637-017-0553-x
- By:
- Publication type:
- Article
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33.
- Published in:
- Scientific Reports, 2016, p. 30555, doi. 10.1038/srep30555
- By:
- Publication type:
- Article
Functional mapping of androgen receptor enhancer activity.
- Published in:
- Genome Biology, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13059-021-02339-6
- By:
- Publication type:
- Article
Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0138958
- By:
- Publication type:
- Article
Systematic Identification and Characterization of RNA Editing in Prostate Tumors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101431
- By:
- Publication type:
- Article
Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability.
- Published in:
- PLoS ONE, 2010, v. 5, n. 9, p. 1, doi. 10.1371/journal.pone.0012661
- By:
- Publication type:
- Article
Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
- Published in:
- Journal of Cellular Biochemistry, 1998, v. 69, n. 3, p. 271, doi. 10.1002/(SICI)1097-4644(19980601)69:3<271::AID-JCB5>3.0.CO;2-O
- By:
- Publication type:
- Article
Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator.
- Published in:
- World Journal of Urology, 2020, v. 38, n. 5, p. 1215, doi. 10.1007/s00345-019-02915-3
- By:
- Publication type:
- Article
Androgens and prostate cancer.
- Published in:
- World Journal of Urology, 2003, v. 21, n. 5, p. 325, doi. 10.1007/s00345-003-0373-9
- By:
- Publication type:
- Article
A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-O11, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 17, p. 1287, doi. 10.1093/jnci/dji252
- By:
- Publication type:
- Article
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3488, doi. 10.3390/cancers13143488
- By:
- Publication type:
- Article
Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2939, doi. 10.3390/cancers13122939
- By:
- Publication type:
- Article
Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer Models.
- Published in:
- Cancers, 2018, v. 10, n. 10, p. 343, doi. 10.3390/cancers10100343
- By:
- Publication type:
- Article
Clusterin Deficiency Predisposes C57BL/6j Mice to Cationic Bovine Serum Albumin-Induced Glomerular Inflammation.
- Published in:
- Journal of Inflammation Research, 2020, v. 13, p. 969, doi. 10.2147/JIR.S285985
- By:
- Publication type:
- Article
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 24, p. 2084, doi. 10.1001/jama.2024.6695
- By:
- Publication type:
- Article
Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 3, p. 480, doi. 10.1002/(SICI)1097-0142(19960801)78:3<480::AID-CNCR15>3.0.CO;2-V
- By:
- Publication type:
- Article
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 22, p. 4332, doi. 10.1002/cam4.4778
- By:
- Publication type:
- Article
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 7, p. 3385, doi. 10.1002/cam4.1587
- By:
- Publication type:
- Article
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.633142
- By:
- Publication type:
- Article
Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 2, p. 389, doi. 10.1002/cncr.21989
- By:
- Publication type:
- Article
Introduction of Clusterin Gene into Human Renal Cell Carcinoma Cells Enhances Their Resistance to Cytotoxic Chemotherapy through Inhibition of Apoptosis both in vitro and in vivo.
- Published in:
- Cancer Science, 2001, v. 92, n. 11, p. 1220, doi. 10.1111/j.1349-7006.2001.tb02143.x
- By:
- Publication type:
- Article
LIN28B promotes the development of neuroendocrine prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prostate cancer: 9. Treatment of advanced disease.
- Published in:
- Canadian Medical Association Journal (CMAJ), 1999, v. 160, n. 2, p. 225
- By:
- Publication type:
- Article
A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.
- Published in:
- Pathology & Oncology Research, 2019, v. 25, n. 3, p. 979, doi. 10.1007/s12253-018-0408-6
- By:
- Publication type:
- Article
Targeted therapy in prostate cancer.
- Published in:
- Histopathology, 2012, v. 60, n. 1, p. 216, doi. 10.1111/j.1365-2559.2011.04030.x
- By:
- Publication type:
- Article